000 01603 a2200445 4500
005 20250513230943.0
264 0 _c20010322
008 200103s 0 0 eng d
022 _a0950-9232
024 7 _a10.1038/sj.onc.1204014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLim, S J
245 0 0 _aGrb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells.
_h[electronic resource]
260 _bOncogene
_cDec 2000
300 _a6271-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAdaptor Proteins, Signal Transducing
650 0 4 _aBreast Neoplasms
_xgenetics
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aDown-Regulation
650 0 4 _aFemale
650 0 4 _aGRB2 Adaptor Protein
650 0 4 _aHumans
650 0 4 _aLiposomes
_xadministration & dosage
650 0 4 _aNeuregulin-1
_xgenetics
650 0 4 _aOligodeoxyribonucleotides, Antisense
_xpharmacology
650 0 4 _aProtein Serine-Threonine Kinases
650 0 4 _aProteins
_xgenetics
650 0 4 _aProto-Oncogene Proteins
_xmetabolism
650 0 4 _aProto-Oncogene Proteins c-akt
650 0 4 _aReceptor, ErbB-2
_xgenetics
650 0 4 _aTransfection
650 0 4 _aTumor Cells, Cultured
700 1 _aLopez-Berestein, G
700 1 _aHung, M C
700 1 _aLupu, R
700 1 _aTari, A M
773 0 _tOncogene
_gvol. 19
_gno. 54
_gp. 6271-6
856 4 0 _uhttps://doi.org/10.1038/sj.onc.1204014
_zAvailable from publisher's website
999 _c11114066
_d11114066